Angiodynamics Inc. (UG2)
XBER 
Summary
Reasons to Hold AngioDynamics Stock in Your Portfolio for Now
ANGO benefits from NanoKnife, clinical milestones and a balanced portfolio despite tariff headwinds.
ANGO Stock Gains Following Q1 Earnings Beat, Gross Margin Improves
AngioDynamics posts narrower-than-expected Q1 loss, 12% revenue growth and margin gains; it also raises FY26 sales outlook, sending shares higher.
AngioDynamics, Inc. (ANGO) Q1 2026 Earnings Call Transcript
AngioDynamics, Inc. (NASDAQ:ANGO ) Q1 2026 Earnings Call October 2, 2025 8:00 AM EDT Company Participants James Clemmer - CEO, President & Director Stephen Trowbridge - Executive VP & CFO Conference Call Participants John Young - Canaccord Genuity Corp., Research Division Frank Takkinen - Lake Street Capital Markets, LLC, Research Division Eduardo Martinez-Montes - H.C. Wainwright & Co, LLC, Research Division Presentation Operator Good morning, and welcome to the AngioDynamics Fiscal Year 2026 First Quarter Earnings Call.
Angiodynamics Inc. (UG2) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
When is the next earnings date?
Has Angiodynamics Inc. ever had a stock split?
Angiodynamics Inc. Profile
| Electronic Equipment, Instruments & Components Industry | Information Technology Sector | James C. Clemmer CEO | XBER Exchange | US03475V1017 ISIN |
| US Country | 748 Employees | - Last Dividend | - Last Split | 27 May 2004 IPO Date |
Overview
AngioDynamics, Inc. is a prominent provider of invasive medical devices, catering to the needs of professional healthcare providers across the United States and internationally. The company specializes in a broad spectrum of medical areas, including vascular access, surgery, peripheral vascular disease, and oncology. Established in 1988, AngioDynamics is committed to enhancing patient outcomes through its innovative technologies and solutions, headquartered in Latham, New York.
Products and Services
- Auryon Atherectomy System: A cutting-edge solution for the treatment of peripheral arterial disease. This system utilizes an optimized wavelength, pulse width, and amplitude to efficiently remove lesions while preserving the vessel wall endothelium.
- Thrombus Management Portfolio:
- AlphaVac System: A mechanical aspiration device designed for emergent situations, obviating the need for perfusionist support.
- Thrombolytic Catheters: These are used to deliver drugs known as thrombolytic agents, intended to dissolve blood clots found in hemodialysis access grafts, arteries, veins, and surgical bypass grafts.
- AngioVac Circuit: Designed for extracorporeal circulatory support for up to six hours. This includes a pump, filter, and reinfusion cannula to facilitate venous drainage during bypass procedures.
- NanoKnife IRE Ablation System: Offers a non-traditional thermal approach for the surgical ablation of soft tissue, providing an alternative to conventional methods.
- Peripheral Products: This category includes a range of products such as angiographic catheters, diagnostic and interventional guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits. These are essential tools for peripheral diagnostic and interventional procedures.
- Drainage Catheters: A diverse range of catheters for various purposes, including multi-purpose/general, nephrostomy, and biliary drainage.
- Micro Access Kits: Provides interventional physicians with a smaller introducer system for conducting minimally invasive procedures.
- VenaCure EVLT System: Utilized in endovascular laser procedures to treat superficial venous disease, showcasing the company's commitment to vascular health.
- Solero MTA System: Comprising the Solero microwave generator and specially designed Solero MW applicators, this system targets microwave thermal ablation processes.
Contact Information
